Citations (25)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (16)
Gary Tse, Benjamin Emmanuel, Cono Ariti, Mona Bafadhel, Alberto Papi, Victoria Carter, Jiandong Zhou, Derek Skinner, Xiao Xu, Hana Müllerová & David Price. (2023) A Long-Term Study of Adverse Outcomes Associated With Oral Corticosteroid Use in COPD. International Journal of Chronic Obstructive Pulmonary Disease 18, pages 2565-2580.
Read now
Read now
Enrico de Nigris, John Haughney, Amanda J. Lee, Mintu Nath, Hana Müllerová, Ulf Holmgren & Bo Ding. (2023) Short- and Long-Term Impact of Prior Chronic Obstructive Pulmonary Disease Exacerbations on Healthcare Resource Utilization and Related Costs: An Observational Study (SHERLOCK). COPD: Journal of Chronic Obstructive Pulmonary Disease 20:1, pages 92-100.
Read now
Read now
João Cardoso, António Jorge Ferreira, Miguel Guimarães, Ana Sofia Oliveira, Paula Simão & Maria Sucena. (2021) Treatable Traits in COPD – A Proposed Approach. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 3167-3182.
Read now
Read now
Claus F Vogelmeier, Joanna Diesing, Nils Kossack, Marc Pignot & Felix W Friedrich. (2021) COPD Exacerbation History and Impact on Future Exacerbations – 8-Year Retrospective Observational Database Cohort Study from Germany. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2407-2417.
Read now
Read now
Morgan Justice Fuoco, Richard A Mularski, Benjamin Wu, Chad Moretz, Mary Ann McBurnie, Richard H Stanford, Phillip Crawford, Daniel Gratie & Bianca Salas. (2021) Continuity of Care Assessment Within a Vertically Integrated Care Management Organization Before and After COPD-Related Exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 16, pages 2755-2767.
Read now
Read now
Jaco Voorham, Simonetta Baldi, Luigi Santoro, Marjan Kerkhof, Marco Contoli, Leonardo M Fabbri, Huib A M Kerstjens, Jose Luis López-Campos, Nicolas Roche, Dave Singh, Claus F Vogelmeier & David B Price. (2020) Extrafine Beclometasone Dipropionate/Formoterol Fumarate vs Double Bronchodilation Therapy in Patients with COPD: A Historical Real-World Non-Inferiority Study. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 2739-2750.
Read now
Read now
Bhavesh Lakhotia, Ronan Mahon, Florian S Gutzwiller, Andriy Danyliv, Ivan Nikolaev & Praveen Thokala. (2020) Modelling the Cost-Effectiveness of Indacaterol/Glycopyrronium versus Salmeterol/Fluticasone Using a Novel Markov Exacerbation-Based Approach. International Journal of Chronic Obstructive Pulmonary Disease 15, pages 787-797.
Read now
Read now
Hana Müllerová, Wilhelmine H Meeraus, Dmitry V Galkin, Frank C Albers & Sarah H Landis. (2019) Clinical burden of illness among patients with severe eosinophilic COPD. International Journal of Chronic Obstructive Pulmonary Disease 14, pages 741-755.
Read now
Read now
Jee Youn Oh, Young Seok Lee, Kyung Hoon Min, Gyu Young Hur, Sung Yong Lee, Kyung Ho Kang, Chin Kook Rhee, Seoung Ju Park & Jae Jeong Shim. (2018) Difference in systemic inflammation and predictors of acute exacerbation between smoking-associated COPD and tuberculosis-associated COPD. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 3381-3387.
Read now
Read now
John R Hurst, Maria Dilleen, Kevin Morris, Siân Hills, Birol Emir & Rupert Jones. (2018) Factors influencing treatment escalation from long-acting muscarinic antagonist monotherapy to triple therapy in patients with COPD: a retrospective THIN-database analysis. International Journal of Chronic Obstructive Pulmonary Disease 13, pages 781-792.
Read now
Read now
Anjan Nibber, Alison Chisholm, Juan José Soler-Cataluña, Bernardino Alcazar, David Price & Marc Miravitlles. (2017) Validating the Concept of COPD Control: A Real-world Cohort Study from the United Kingdom. COPD: Journal of Chronic Obstructive Pulmonary Disease 14:5, pages 504-512.
Read now
Read now
Martine Hoogendoorn, Talitha L Feenstra, Melinde Boland, Andrew H Briggs, Sixten Borg, Sven-Arne Jansson, Nancy A Risebrough, Julia F Slejko & Maureen PMH Rutten-van Mölken. (2017) Prediction models for exacerbations in different COPD patient populations: comparing results of five large data sources. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 3183-3194.
Read now
Read now
Yusheng Cheng, Xiongwen Tu, Linlin Pan, Shuai Lu, Ming Xing, Linlin Li & Xingwu Chen. (2017) Clinical characteristics of chronic bronchitic, emphysematous and ACOS phenotypes in COPD patients with frequent exacerbations. International Journal of Chronic Obstructive Pulmonary Disease 12, pages 2069-2074.
Read now
Read now
Dermot Ryan, John Blakey, Alison Chisholm, David Price, Mike Thomas, Björn Ställberg, Karin Lisspers & Janwillem W. H. Kocks. (2017) Use of electronic medical records and biomarkers to manage risk and resource efficiencies. European Clinical Respiratory Journal 4:1.
Read now
Read now
Marc Miravitlles, Heinrich Worth, Juan José Soler-Cataluña, David Price, Fernando De Benedetto, Nicolas Roche, Nina S. Godtfredsen, Thys van der Molen, Claes-Göran Löfdahl, Laura Padullés & Anna Ribera. (2016) The Relationship Between 24-Hour Symptoms and COPD Exacerbations and Healthcare Resource Use: Results from an Observational Study (ASSESS). COPD: Journal of Chronic Obstructive Pulmonary Disease 13:5, pages 561-568.
Read now
Read now
Hye Seon Kang, Chin Kook Rhee, Sung Kyoung Kim, Jin Woo Kim, Sang Haak Lee, Hyung Kyu Yoon, Joong Hyun Ahn & Yong Hyun Kim. (2016) Comparison of the clinical characteristics and treatment outcomes of patients requiring hospital admission to treat eosinophilic and neutrophilic exacerbations of COPD. International Journal of Chronic Obstructive Pulmonary Disease 11, pages 2467-2473.
Read now
Read now
Articles from other publishers (9)
Naresh Kumar, Rashmi Mishra, Mradul K Daga, Govind Mawari, Ishan Rohatgi & HS Hira. (2022) Dyspnea, Obstruction, Smoking, Exacerbation Index, and Chronic Obstructive Pulmonary Disease Test Score: Correlation in Predicting Outcomes in Patients with Chronic Obstructive Pulmonary Disease Exacerbations. The Indian Journal of Chest Diseases and Allied Sciences 64:3, pages 153-159.
Crossref
Crossref
Elena V. Bolotova, Anna V. Dudnikova & Larisa V. Shulzhenko. (2022) Experience of using a triple fixed combination in the treatment of patients with chronic obstructive pulmonary disease. Terapevticheskii arkhiv 94:3, pages 396-400.
Crossref
Crossref
Siyang Zeng, Mehrdad Arjomandi & Gang Luo. (2022) Automatically Explaining Machine Learning Predictions on Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. JMIR Medical Informatics 10:2, pages e33043.
Crossref
Crossref
Siyang Zeng, Mehrdad Arjomandi, Yao Tong, Zachary C Liao & Gang Luo. (2022) Developing a Machine Learning Model to Predict Severe Chronic Obstructive Pulmonary Disease Exacerbations: Retrospective Cohort Study. Journal of Medical Internet Research 24:1, pages e28953.
Crossref
Crossref
Gang Luo, Bryan L Stone, Xiaoming Sheng, Shan He, Corinna Koebnick & Flory L Nkoy. (2021) Using Computational Methods to Improve Integrated Disease Management for Asthma and Chronic Obstructive Pulmonary Disease: Protocol for a Secondary Analysis. JMIR Research Protocols 10:5, pages e27065.
Crossref
Crossref
S N Avdeev, N V Trushenko, Z M Merzhoeva, M S Ivanova & E V Kusraeva. (2019) Eosinophilic inflammation in chronic obstructive pulmonary disease. Terapevticheskii arkhiv 91:10, pages 144-152.
Crossref
Crossref
Graham Devereux, Seonaidh Cotton, Shona Fielding, Nicola McMeekin, Peter J Barnes, Andy Briggs, Graham Burns, Rekha Chaudhuri, Henry Chrystyn, Lisa Davies, Anthony De Soyza, Simon Gompertz, John Haughney, Karen Innes, Joanna Kaniewska, Amanda Lee, Alyn Morice, John Norrie, Anita Sullivan, Andrew Wilson & David Price. (2019) Low-dose oral theophylline combined with inhaled corticosteroids for people with chronic obstructive pulmonary disease and high risk of exacerbations: a RCT. Health Technology Assessment 23:37, pages 1-146.
Crossref
Crossref
Jongmin Lee, Hyun Myung Jung, Sook Kyung Kim, Kwang Ha Yoo, Ki-Suck Jung, Sang Haak Lee & Chin Kook Rhee. (2019) Factors associated with chronic obstructive pulmonary disease exacerbation, based on big data analysis. Scientific Reports 9:1.
Crossref
Crossref
M. Reza Maleki-Yazdi, Mathieu Molimard, Dorothy L. Keininger, Jean-Bernard Gruenberger, Joao Carrasco, Claudia Pitotti, Elsa Sauvage, Sara Chehab & David Price. (2016) Cost Effectiveness of the Long-Acting β2-Adrenergic Agonist (LABA)/Long-Acting Muscarinic Antagonist Dual Bronchodilator Indacaterol/Glycopyrronium Versus the LABA/Inhaled Corticosteroid Combination Salmeterol/Fluticasone in Patients with Chronic Obstructive Pulmonary Disease: Analyses Conducted for Canada, France, Italy, and Portugal. Applied Health Economics and Health Policy 14:5, pages 579-594.
Crossref
Crossref